Report #2888209

Received Mar 9, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: PA
Recovered: Unknown
Vaccinated: Mar 5, 2026
Onset: Mar 5, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HPV9	HPV (GARDASIL 9)	MERCK & CO. INC.	3	Z005055	—

Symptoms (2)

Expired product administeredNo adverse event

Symptom narrative

No other AE; patient being administered an expired dose of GARDASIL 9 as her 3rd dose in a 3-dose regimen; This spontaneous report was received from a registered nurse (R. N.)concerning a 32-year-old female patient. The patient's medical history, concurrent conditions, concomitant medications and drug reactions/allergies were not reported. Her historical drugs included the first and second doses of HPV vaccine VLP rL1 9v (yeast) (GARDASIL 9.) On 05-Mar-2026, the patient was administered an expired dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) suspension for injection, 0.5 mL, batch/lot number Z005055, expiration date 27-Feb-2026, as her third dose in a 3-dose regimen for prophylaxis (expired product administered) (anatomical location and route of administration were not reported.) There were no other adverse events (AE) (no adverse event.)